A histamine H2 receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade

Basic Research in Cardiology

Volumn 105, Issue 6, 2010, Pages 787-794

  Takahama, Hiroyuki ^a   Asanuma, Hiroshi ^a,b   Sanada, Shoji ^c   Fujita, Masashi ^c   Sasaki, Hideyuki ^a   Wakeno, Masakatsu ^a   Kim, Jiyoong ^a   Asakura, Masanori ^a   Takashima, Seiji ^c   Minamino, Tetsuo ^c   Komamura, Kazuo ^a   Sugimachi, Masaru ^a   Kitakaze, Masafumi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenergic receptor blocker; Heart failure; Histamine; Histamine H2 receptor blocker

Indexed keywords

CARVEDILOL; CARVEDIOL PLUS FAMOTIDINE; CYCLIC AMP; FAMOTIDINE; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARDIOTONIC AGENT; PROPANOLAMINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXPERIMENTAL DOG; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; LUNG CAPILLARY; LUNG WEDGE PRESSURE; NONHUMAN; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; ANIMAL; DISEASE MODEL; DOG; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART STROKE VOLUME; MAST CELL; METABOLISM; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; CARDIAC PACING, ARTIFICIAL; CARDIOTONIC AGENTS; CYCLIC AMP; DISEASE MODELS, ANIMAL; DOGS; ECHOCARDIOGRAPHY; FAMOTIDINE; HEART CATHETERIZATION; HEART FAILURE; HISTAMINE; HISTAMINE H2 ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MAST CELLS; PROPANOLAMINES; PULMONARY WEDGE PRESSURE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 78649329151     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-010-0119-y     Document Type: Article

References (36)

1. 2 receptors protects the heart against ischemia and reperfusion injury in dogs J Mol Cell Cardiol 40 666 674 1:CAS:528:DC%2BD28XjvVGmtrg%3D 10.1016/j.yjmcc.2006.02.001 16603184
2. MR Bristow EM Gilbert WT Abraham KF Adams MB Fowler RE Hershberger SH Kubo KA Narahara H Ingersoll S Krueger S Krueger S Young N Shusterman 1996 Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation 94 2807 2816 1:CAS:528:DyaK2sXlsVShuw%3D%3D 8941106
3. MR Bristow R Ginsburg DC Harrison 1982 Histamine and the human heart: the other receptor system Am J Cardiol 49 249 251 1:STN:280:DyaL38%2FovVClsQ%3D%3D 10.1016/0002-9149(82)90298-3 7032271 (Pubitemid 12003527)
4. MR Bristow 1997 Mechanism of action of beta-blocking agents in heart failure Am J Cardiol 80 26L 40L 1:CAS:528:DyaK1cXhsFSgtw%3D%3D 10.1016/S0002-9149(97)00846-1 9412540
5. OE Brodde S Hillemann K Kunde M Vogelsang HR Zerkoski 1992 Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure J Heart Lung Transplant 11 S164 S174 1:STN:280:DyaK38zosFCltw%3D%3D 1355362
6. L Brown B Lorenz E Erdmann 1986 Reduced positive inotropic effects in diseased human ventricular myocardium Cardiovasc Res 20 516 520 1:CAS:528:DyaL28Xkslagurs%3D 10.1093/cvr/20.7.516 2430709 (Pubitemid 16058114)
7. CIBIS II Investigators and Committees 1999 The cardiac insufficiency bisoprolol study II (CIBIS II): a randomized trial Lancet 353 9 13 10.1016/S0140-6736(98)11181-9 (Pubitemid 29037695)
8. AM Dvorak 1986 Mast-cell degranulation in human hearts N Engl J Med 315 969 970 1:STN:280:DyaL2s%2FhsVGrtQ%3D%3D 3762601
9. EJ Eichhorn 1998 Restoring function in failing hearts: the effects of beta blockers Am J Med 104 163 169 1:STN:280:DyaK1c7oslGrtw%3D%3D 10.1016/S0002-9343(97)00171-X 9528736 (Pubitemid 28117412)
10. 2 receptor Proc Natl Acad Sci USA 88 5937 1:CAS:528:DyaK38XhsFCk 10.1073/pnas.88.13.5937a 2062872
11. M Hara K Ono MW Hwang A Iwasaki M Okada K Nakatani S Sasayama A Matsumori 2002 Evidence for a role of mast cells in the evolution to congestive heart failure J Exp Med 195 375 381 1:CAS:528:DC%2BD38Xht1WjtL4%3D 10.1084/jem.20002036 11828013 (Pubitemid 34461496)
12. Y Hattori 1999 Cardiac histamine receptors: their pharmacological consequences and signal transduction pathways Methods Find Exp Clin Pharmacol 21 123 131 1:CAS:528:DyaK1MXjtF2lsL0%3D 10.1358/mf.1999.21.2.529239 10327393
13. 2-receptor antagonists Clin Pharmacol Ther 48 302 308 1:CAS:528:DyaK3MXktlY%3D 10.1038/clpt.1990.153 1976052
14. SJ Hill CR Ganellin H Timmerman JC Schwartz NP Shankley JM Young W Schunack R Levi HL Haas 1997 International Union of Pharmacology. XIII. Classification of histamine receptors Pharmacol Rev 49 253 278 1:CAS:528:DyaK2sXmtl2hsbo%3D 9311023
15. M Jessup S Brozena 2003 Heart failure N Engl J Med 348 2007 2018 10.1056/NEJMra021498 12748317 (Pubitemid 36569990)
16. 2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies J Am Coll Cardiol 48 1378 1384 1:CAS:528:DC%2BD28XhtVagtLfE 10.1016/j.jacc.2006.05.069 17010798 (Pubitemid 44436824)
17. K Leineweber M Bohm G Heusch 2006 Cyclic adenosine monophosphate in acute myocardial infarction with heart failure Slayer or savior? Circulation 114 365 367 10.1161/CIRCULATIONAHA.106.642132 16880340
18. 2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans J Pharmacol Exp Ther 309 786 795 1:CAS:528:DC%2BD2cXjs1ygsrc%3D 10.1124/jpet.103.063065 14752062 (Pubitemid 38542635)
19. M Metra R Giubbini S Nodari E Boldi MG Modena LD Cas 2000 Differential effects of beta-blockers in patients with heart failure Circulation 102 546 551 1:CAS:528:DC%2BD3cXlvFKhur0%3D 10920067
20. MA Movsesian 1999 Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphatase J Am Coll Cardiol 34 318 324 1:CAS:528: DyaK1MXmvFalt7g%3D 10.1016/S0735-1097(99)00220-X 10440139
21. 2 histamine receptor antagonists loratadine and ranitidine on autonomic control of the heart Anesthesiology 96 336 341 1:CAS:528: DC%2BD38XhsVGnur8%3D 10.1097/00000542-200202000-00018 11818765
22. T Neumann G Heusch 1997 Myocardial, skeletal muscle, and renal blood flow during exercise in conscious dogs with heart failure Am J Physiol 273 H2452 H2457 1:CAS:528:DyaK2sXnsVCrs7g%3D 9374784
23. T Neumann A Vollmer TH Schaffner OM Hess G Heusch 1999 Diastolic dysfunction and collagen structure in canine pacing-induced heart failure J Mol Cell Cardiol 31 179 192 1:CAS:528:DyaK1MXhvVWmtrY%3D 10.1006/jmcc.1998.0853 10072726 (Pubitemid 29078229)
24. K Okada T Minamino Y Tsukamoto Y Liao O Tsukamoto S Takashima A Hirata M Fujita Y Nagamachi T Nakatani C Yutani K Ozawa S Ogawa H Tomoike M Hori M Kitakaze 2004 Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis Circulation 110 705 712 10.1161/01.CIR.0000137836.95625.D4 15289376 (Pubitemid 39056270)
25. M Packer AJ Coats MB Fowler MB Fowler HA Katus H Krum P Mohacsi JL Rouleau M Tendera A Castaigne EB Roecker MK Schultz DL DeMets Carvedilol Prospective Randomized Cumulative Survival Study group 2001 Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 1651 1658 1:CAS:528:DC%2BD3MXkslWjt7c%3D 10.1056/NEJM200105313442201 11386263 (Pubitemid 32479962)
26. V Patella I Marino E Arbustini B Lamparter-Schummert L Verga M Adt G Marone 1998 Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy Circulation 97 971 978 1:STN:280:DyaK1c7ovVWitg%3D%3D 9529265
27. H Sasaki H Asanuma M Fujita H Takahama M Wakeno S Ito A Ogai M Asakura J Kim T Minamino S Takashima S Sanada M Sugimachi K Komamura N Mochizuki M Kitakaze 2009 Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase Circulation 119 2568 2577 1:CAS:528: DC%2BD1MXmtVKntrg%3D 10.1161/CIRCULATIONAHA.108.798561 19414638
28. G Schultz W Rosenthal J Hescheler 1990 Role of G proteins in calcium channel modulation Annu Rev Physiol 52 275 292 1:CAS:528:DyaK3cXlvVymtrY%3D 10.1146/annurev.ph.52.030190.001423 1691905
29. 1-antihistamines N Engl J Med 351 2203 2217 1:CAS:528:DC%2BD2cXhtVSqtLzF 10.1056/NEJMra033121 15548781 (Pubitemid 39507633)
30. A Sugiyama Y Satoh A Takahara Y Nakamura M Shimizu-Sasamata S Sato K Miyata K Hashimoto 2003 Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems Eur J Pharmacol 466 137 146 1:CAS:528:DC%2BD3sXisV2rsro%3D 10.1016/S0014-2999(03)01559-0 12679150 (Pubitemid 36385099)
31. T Takahashi T Tang C Lai DM Roth B Rebolledo M Saito WYW Lew P Clopton K Hammond 2006 Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction Circulation 114 388 396 1:CAS:528:DC%2BD28Xnt1agsbg%3D 10.1161/CIRCULATIONAHA.106.632513 16864723 (Pubitemid 44264820)
32. The MERIT-HF Study Group 1999 Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 2001 2007 10.1016/S0140-6736(99)04440-2 (Pubitemid 29271744)
33. W Trautwein J Hescheler 1990 Regulation of cardiac L-type calcium current by phosphorylation and G proteins Annu Rev Physiol 52 257 274 1:CAS:528:DyaK3cXlvVymtrk%3D 10.1146/annurev.ph.52.030190.001353 2158764
34. RP Xiao H Cheng YY Zhou M Kuschel EG Lakatta 1999 Recent advances in cardiac beta(2)-adrenergic signal transduction Circ Res 85 1092 1100 1:CAS:528:DyaK1MXns1Ontbg%3D 10571541
35. HR Zeekowski A Broede K Kunde S Hillemann E Schafer M Vogelsang MC Michel OE Brodde 1993 Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium Naunyn-Schemiedeberg's Arch Phamacol 347 347 352 10.1007/BF00165383
36. R Zhou P Moench C Heran X Lu N Mathias TN Faria DA Wall MA Hussain RL Smith D Sun 2005 pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of canine model Pharm Res 22 188 192 1:CAS:528:DC%2BD2MXitlClt74%3D 10.1007/s11095-004-1185-3 15783065 (Pubitemid 40487201)